Market Research Report
Medical Marijuana and the Opioid Crisis
|Published by||BCC Research||Product code||866729|
|Published||Content info||15 Pages
Delivery time: 1-2 business days
|Medical Marijuana and the Opioid Crisis|
|Published: June 10, 2019||Content info: 15 Pages||
Just in 2017, medical cannabis totaled $7.3 billion, up from $4.8 billion in 2016. This segment will likely achieve a 22.2% CAGR to reach nearly $19.8 billion at the producer level in 2022 and will account to more than 80% of the global market. Politics aside, one must remember that marijuana is still a drug and needs to be treated as such with its potential side effects. Even if cannabinoids-based drugs will not fully substitute opioid use, combination of medical marijuana use with reduced dose of opioid will help to curb the crisis.